Literature DB >> 25458989

SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis.

Martin E Rottenberg1, Berit Carow2.   

Abstract

In our review, we address the role of signal transducer and activator of transcription-3 (STAT3) and suppressor of cytokine signaling-3 (SOCS3) in the outcome of Mycobacterium tuberculosis infection, focusing on functions of these molecules in regulating the biology of myeloid and lymphoid cells. The STAT3 transcription factor has paradoxical roles: mainly activating an anti-inflammatory program in myeloid cells while promoting the differentiation and activation of inflammatory T cells. STAT3 is a major player in all phases of T cell responses, including T cell subset differentiation, T cell activation, and generation of memory. We review the roles of cytokines that activate, or are activated by, STAT3 during the infection with M. tuberculosis. SOCS3 inhibits STAT3 activation, by some but not all STAT3-activating cytokine receptors. Infection with M. tuberculosis also stimulates SOCS3 expression in phagocytes. Studies in different mouse models have proven the critical importance of SOCS3 in restraining inflammation and allowing optimal levels of protective immune responses against the infection. The accumulated data presented here suggest a relevant program coordinated by SOCS3 in different cell populations, which results in improved control of infection with M. tuberculosis. STAT3 and SOCS3 may thus be targeted to improve the control of infection with M. tuberculosis or the efficiency of vaccination.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dendritic cell; M. tuberculosis; Macrophage; SOCS3; STAT3; T cell

Mesh:

Substances:

Year:  2014        PMID: 25458989     DOI: 10.1016/j.smim.2014.10.004

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  32 in total

1.  Tuberculosis is associated with expansion of a motile, permissive and immunomodulatory CD16(+) monocyte population via the IL-10/STAT3 axis.

Authors:  Claire Lastrucci; Alan Bénard; Luciana Balboa; Karine Pingris; Shanti Souriant; Renaud Poincloux; Talal Al Saati; Voahangy Rasolofo; Pablo González-Montaner; Sandra Inwentarz; Eduardo Jose Moraña; Ivanela Kondova; Frank A W Verreck; Maria del Carmen Sasiain; Olivier Neyrolles; Isabelle Maridonneau-Parini; Geanncarlo Lugo-Villarino; Céline Cougoule
Journal:  Cell Res       Date:  2015-10-20       Impact factor: 25.617

Review 2.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

3.  The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling.

Authors:  Kimberly M Sogi; Katie A Lien; Jeffrey R Johnson; Nevan J Krogan; Sarah A Stanley
Journal:  ACS Infect Dis       Date:  2017-06-05       Impact factor: 5.084

4.  IL-24 Promotes Pseudomonas aeruginosa Keratitis in C57BL/6 Mouse Corneas.

Authors:  Bing X Ross; Nan Gao; Xinhan Cui; Theodore J Standiford; Jianjiang Xu; Fu-Shin X Yu
Journal:  J Immunol       Date:  2017-03-22       Impact factor: 5.422

5.  STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis.

Authors:  Omar Nunez Lopez; Fredrick J Bohanon; Xiaofu Wang; Na Ye; Tiziana Corsello; Yesenia Rojas-Khalil; Haijun Chen; Haiying Chen; Jia Zhou; Ravi S Radhakrishnan
Journal:  RSC Adv       Date:  2016-10-14       Impact factor: 3.361

6.  miR-455-5p regulates atrial fibrillation by targeting suppressor of cytokines signaling 3.

Authors:  Weiling Li; Na Qi; Shuo Wang; Wenyan Jiang; Tao Liu
Journal:  J Physiol Biochem       Date:  2021-04-01       Impact factor: 4.158

7.  Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients.

Authors:  Monika M Vivekanandan; Ernest Adankwah; Wilfred Aniagyei; Isaac Acheampong; Augustine Yeboah; Joseph F Arthur; Millicent N K Lamptey; Mohammed K Abass; Amidu Gawusu; Francis Kumbel; Francis Osei-Yeboah; Linda Batsa Debrah; Dorcas O Owusu; Alexander Debrah; Ertan Mayatepek; Julia Seyfarth; Richard O Phillips; Marc Jacobsen
Journal:  Infection       Date:  2022-06-27       Impact factor: 3.553

8.  Expression of mycobacterium tuberculosis induced SOCS3 and STAT3 and the implications on innate immunity in TB patients vs healthy contacts in high TB/HIV endemic setting: A cross-sectional analytical study.

Authors:  Patrick Lungu; Kabaso Mushota; Evarist Njelesani; Thomas Sukwa; Shabir Lakhi; Peter Mwaba
Journal:  PLoS One       Date:  2022-07-15       Impact factor: 3.752

9.  Blood transcriptomic markers of Mycobacterium tuberculosis load in sputum.

Authors:  K M Dupnik; J M Bean; M H Lee; M A Jean Juste; L Skrabanek; V Rivera; C K Vorkas; J W Pape; D W Fitzgerald; M Glickman
Journal:  Int J Tuberc Lung Dis       Date:  2018-08-01       Impact factor: 2.373

10.  Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients.

Authors:  Kirstin Harling; Ernest Adankwah; Alptekin Güler; Anthony Afum-Adjei Awuah; Louis Adu-Amoah; Ertan Mayatepek; Ellis Owusu-Dabo; Norman Nausch; Marc Jacobsen
Journal:  Cell Mol Immunol       Date:  2018-03-19       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.